drugset / Trial / NCT03251625

Multi-strain Probiotic in the Management of IBS-D

NCT03251625 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

1. To assess the effect of multistrain probiotics on abdominal pain using a validated symptom severity score in IBS patients. 2. To assess the efficacy of a multi-strain probiotic supplement as a treatment option for IBS in a tertiary referral centre

Timeline

Start
2015-04
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bio-Kult® Other / unclassified 8e+09 unknown —